Similarly, the enzyme phenylalanine hydroxylase (PAH), of which genetic mutations lead to PKU, is activated by its own substrate phenylalanine (Phe), postulated to bind not only to the enzyme active site in the catalytic domain, but also to a separate regulatory domain (Zhang et al 2014) (Fig. 2b). Here, PAH is linked to phenylketonuria.